Company intelligence / Profile preview

International Penta Financial Services

Vaduz, Liechtenstein

Ownership: Private
Development stage: Other

Overview

International Penta Financial Services is a Liechtenstein-based investment and financial services firm primarily known for its significant holdings and activist involvement in the life sciences sector. The company gained prominence as a major shareholder in Helix BioPharma Corp., a Canadian biopharmaceutical company focused on cancer therapies. Led by Herald Janssen, the firm has historically engaged in corporate governance and strategic oversight within its portfolio companies. While its primary business is financial services and investment management, its activities are heavily concentrated in the biotechnology and healthcare industries through strategic equity positions.

Industry: Investors

Beyond the preview

Go deeper on International Penta Financial Services.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on International Penta Financial Services.

Explore the full profile